Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biomarin
Biomarin
3 Biotech Stocks Buoyed By Potential Blockbuster Drugs
Investors.com
Sat, 05/7/16 - 01:13 pm
JCAR015
Juno Therapeutics
Kyndrisa
Biomarin
Intercept Pharma
Ocaliva
BioMarin announces 'encouraging' early-stage hemophilia therapy data
Marketwatch
Wed, 04/20/16 - 09:37 am
Biomarin
hemophilia
BMN 270
BioMarin drug for genetic disorder succeeds in late-stage study
Yahoo/Reuters
Mon, 03/21/16 - 09:01 am
Biomarin
clinical trials
pegvaliase
5 Key FDA Decisions Expected in March
24/7 Wall St
Mon, 03/14/16 - 10:02 am
FDA
Rayaldee
OPKO Health
Nuplazid
Acadia
abaloparatide
Radius Health
pegvaliase
Biomarin
ALD403
Alder Biopharmaceuticals
Sanofi scouts for rare disease buyouts as Shire bears down on the field
Fierce Biotech
Tue, 03/1/16 - 09:37 am
Sanofi
Shire
M&A
R&D
Biomarin
Ionis Pharmaceuticals
Ultragenyx
Why the FDA shouldn’t bow to parental pressure over Duchenne drug
Stat
Tue, 01/26/16 - 09:17 pm
FDA
Duchenne Muscular Dystrophy
drug approvals
Biomarin
Sarepta Therapeutics
BioMarin Fails to Win Approval for Drug to Treat Deadly Duchenne
Bloomberg
Thu, 01/14/16 - 10:07 am
Biomarin
FDA
Duchenne Muscular Dystrophy
Kyndrisa
drisapersen
4 Top FDA Decisions Expected in Q1
24/7 Wall St
Mon, 01/4/16 - 10:05 am
FDA
Zafgen
beloranib
Biomarin
Peg-Pal
PB272
Puma Biotechnology
Aquinox
AQX-1125
What Does 2016 Hold for Biotech Stocks?
Motley Fool
Sun, 01/3/16 - 10:27 pm
biotech
Gilead Sciences
Celgene
Amgen
Regeneron
Sanofi
Biomarin
Sarepta Th
How Gilead Sciences M&A Can Pan Out Next Year
Bidness, ETC
Tue, 12/29/15 - 09:36 am
Gilead Sciences
M&A
Vertex Pharmaceuticals
Incyte
Biomarin
Regeneron
BioMarin Announces That FDA Has Advised it Will Not Take Action on the Kyndrisa™ (drisapersen) New Drug Application by the PDUFA Date
Yahoo
Fri, 12/18/15 - 09:07 am
Biomarin
FDA
drisapersen
Kyndrisa
Duchenne Muscular Dystrophy
FDA Committee Raises Concerns about Kyndrisa’s Efficacy, Safety
Yahoo/Market Realist
Fri, 12/11/15 - 10:27 pm
FDA
Kyndrisa
Duchenne Muscular Dystrophy
Biomarin
drisapersen
BioMarin: So You’re Saying There’s a Chance?
Barron's
Wed, 11/25/15 - 11:31 am
Biomarin
Duchenne Muscular Dystrophy
drisapersen
Kyndrisa
FDA
BioMarin Duchenne drug appears destined for failure after brutal FDA meeting
BioPharma Dive
Wed, 11/25/15 - 10:53 am
Biomarin
Duchenne Muscular Dystrophy
FDA
advisory panels
drisapersen
The first drug for Duchenne will be reviewed at the FDA today: Why it matters
Bizjournals.com
Tue, 11/24/15 - 09:51 am
FDA
Biomarin
advisory panels
Duchenne Muscular Dystrophy
Kyndrisa
drisapersen
BioMarin FDA Panel Live Blog
TheStreet.com
Tue, 11/24/15 - 09:06 am
Biomarin
FDA
advisory panels
Duchenne Muscular Dystrophy
drisapersen
Duchenne moms say FDA documents ‘widen the divide’ between drugs by BioMarin, Sarepta
Bizjournals.com
Fri, 11/20/15 - 06:19 pm
Duchenne Muscular Dystrophy
FDA
eterplirsen
drisapersen
Biomarin
Sarepta Therapeutics
FDA staff unveils strongly critical review of BioMarin Duchenne drug ahead of crucial meeting
BioPharma Dive
Fri, 11/20/15 - 11:11 am
FDA
Biomarin
Duchenne Muscular Dystrophy
drisapersen
Experts say Sarepta has a clear edge over BioMarin in Duchenne drug battle
Bizjournals.com
Thu, 11/5/15 - 12:47 pm
Sarepta Therapeutics
Biomarin
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
FDA ‘Weirdness?’ Separate meetings for BioMarin and Sarepta DMD drugs
Pharmalot
Thu, 10/15/15 - 03:59 pm
FDA
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »